The finding suggests that gene mutations responsible for antibiotic resistance occurred naturally in 1,000-year-old bacteria and are not necessarily linked to the overuse of antibiotics.
An international team of scientists analysed the microbiome of the remains that were mummified naturally in the cold climate of the Andes Mountains.
Found in Cuzco, the ancient capital of the Inca empire, the mummy is currently stored in the Museum of Anthropology and Ethnology of the University of Florence, Italy.
Gino Fornaciari, professor of history of medicine and paleopathology at the University of Pisa, and colleagues carried out an autopsy on the mummy, 'Discovery News' reported.
The mummified heart, esophagus and colon (containing an enormous amount of feces) were abnormally enlarged, suggesting a symptom of a chronic case of Chagas' disease - a potentially life-threatening condition caused by the protozoan parasite Trypanosoma cruzi.
A team of international researchers from California, Puerto Rico and Italy directed by Raul Cano, a professor at the California Polytechnic State University, was able to fully sequence the bacteria DNA in the mummy's colon and feces.
The woman survived for some time, despite having advanced heart disease, megacolon and megaesophagus, suggesting that she was probably treated with drugs, possibly coca leaves.
Analysis of the mummy's microbiome also showed the presence of other disease caused by bacteria, such as Clostridium difficile, from which C difficile infection that causes diarrhea and colitis originates, and some types of human papilloma virus (HPV), a sexually transmitted virus which causes cervical cancer.
While the recovered T cruzi appeared more primitive than modern forms of the modern parasite, it was 98 to 99 per cent similar to today's virus.
"In particular, vancomycin was discovered more than 50 years ago, and vancomycin-resistant genes have been mainly implicated with the increased use of this antibiotic," the researchers said.
The gut microbiome of the mummy, however, shows that antibiotic-resistant genes predate therapeutic use of these compounds.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
